22 julio 2020
Yesterday investors traded on a risk-on mood on the back of an historical agreement in the EU. The €750bn stimulus plan agreed will consist of €390bn in grants and €360bn in loans.
Evolution of the international financial markets and evaluation of the main events and economic indicators of the previous day session. Available in English.
Yesterday investors traded on a risk-on mood on the back of an historical agreement in the EU. The €750bn stimulus plan agreed will consist of €390bn in grants and €360bn in loans.
In the first session of the week, investor sentiment improved as promising trial results from a potential COVID-19 vaccine renewed investor's hopes.
In the last session of the week, investors traded cautiously as they pondered over an uncertain economic outlook. Stocks rose moderately in advanced economies while exhibiting a better performance in emerging economies. In FX markets, the USD weakened against most AE currencies.
Investors traded more cautiously in yesterday's session as increasing coronavirus infections weighed on risk sentiment.
Positive developments around a potential COVID-19 vaccine fueled a risk-on mood in yesterday's session. Stocks rose across advanced and emerging economies and, in the U.S., shares of Moderna - a company working on a vaccine - surged close to 7% after a small-scale study showed its experimental vaccine produced high levels of antibodies.
Markets continued to exhibit a mixed performance as investors weighed data releases and increasing COVID-19 infections. European stocks and sovereign yields declined after euro area industrial production had posted a lower-than-expected rebound in May (+12.4% mom and -20.9% yoy). Yet, in FX markets the euro rose towards $1.14.
Global markets started the week with a mixed session. In Europe, stocks rose across the board and sovereign yields advanced as investors eyed negotiations over the EU stimulus plan ahead of the European Council.
Investor sentiment ended the week on the up amid positive reports over a potential antiviral drug to treat COVID-19. As risk appetite rose, stocks increased across Europe and the U.S., the USD weakened and commodity prices advanced (in oil markets, the barrel of Brent closed moderately above $43).
In yesterday's session, investors traded with a risk-off mood due to increased concerns over the speed of the economic recovery as covid-19 cases continue to surge.
In yesterday's session, investors traded cautiously in Europe as the European Commission's downbeat economic projections still weighed on sentiment.